In vitro and in silico biological evaluation of phthalimide derivatives as antiproliferative agents

Fuente: Redalyc
Enregistré dans:
Détails bibliographiques
Auteur principal: Crystel A. Sierra-Rivera
Format: Artículo científico
Langue:en
Publié: Universidad Nacional Autónoma de México 2021
Sujets:
Accès en ligne:
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
_version_ 1876463309748699136
author Crystel A. Sierra-Rivera
author_facet Crystel A. Sierra-Rivera
contents In vitro and in silico biological evaluation of phthalimide derivatives as antiproliferative agents Crystel A. Sierra-Rivera Muhammad Kashif Lenci K. Vázquez-Jiménez Alejandro Zugasti-Cruz Alfredo Juárez-Saldivar Alma D. Paz-González Gildardo Rivera Biología phthalimide Antiproliferative molecular docking DNA methyltransferase 1 Phthalimide is considered a scaffold for the development of new anticancer agents. In this work, the antiproliferative activity of forty-three phthalimide derivatives was evaluated against cervical (HeLa), liver (HepG2), breast (4T1) cancer cell lines, and a normal cell line of murine fibroblasts (3T3). Finally, a molecular docking analysis of phthalimide derivatives on the active site of the enzymes DNA methyltransferase 1 (DNMT1) and vascular endothelial growth factor receptor 2 (VEGR2) as potential drug targets was performed. The compounds, C16, E11, and E16 showed the best antiproliferative activity against the cell lines HeLa and 4T1. Only, the compound H16 decreased 32% cell proliferation against HepG2 cell line. The compounds H5, H16, E2, E16, and C1 did not affect the proliferation of the 3T3 cell line. The molecular docking analysis showed that phthalimide derivatives have a greater affinity for DNMT1 than S-adenosyl-l-homocysteine, a potent DNMT1 inhibitor. However, molecular docking results do not correlate with their antiproliferative effects, suggesting another potential mechanism of action for the active compounds. 2021 artículo científico 1405-888X https://www.redalyc.org/articulo.oa?id=43271644010 https://www.redalyc.org/journal/432/43271644010/ https://www.redalyc.org/journal/432/43271644010/html/ https://www.redalyc.org/journal/432/43271644010/43271644010.epub https://www.redalyc.org/journal/432/43271644010/movil 10.22201/fesz.23958723e.2021.314 en http://www.redalyc.org/revista.oa?id=432 Tip Revista Especializada en Ciencias Químico-Biológicas application/pdf Universidad Nacional Autónoma de México Tip Revista Especializada en Ciencias Químico-Biológicas (México) Vol.24
format Artículo científico
id redalyc_43271644010
institution Redalyc
language en
publishDate 2021
publisher Universidad Nacional Autónoma de México
spellingShingle In vitro and in silico biological evaluation of phthalimide derivatives as antiproliferative agents
Crystel A. Sierra-Rivera
Biología
phthalimide
Antiproliferative
molecular docking
DNA methyltransferase 1
In vitro and in silico biological evaluation of phthalimide derivatives as antiproliferative agents Crystel A. Sierra-Rivera Muhammad Kashif Lenci K. Vázquez-Jiménez Alejandro Zugasti-Cruz Alfredo Juárez-Saldivar Alma D. Paz-González Gildardo Rivera Biología phthalimide Antiproliferative molecular docking DNA methyltransferase 1 Phthalimide is considered a scaffold for the development of new anticancer agents. In this work, the antiproliferative activity of forty-three phthalimide derivatives was evaluated against cervical (HeLa), liver (HepG2), breast (4T1) cancer cell lines, and a normal cell line of murine fibroblasts (3T3). Finally, a molecular docking analysis of phthalimide derivatives on the active site of the enzymes DNA methyltransferase 1 (DNMT1) and vascular endothelial growth factor receptor 2 (VEGR2) as potential drug targets was performed. The compounds, C16, E11, and E16 showed the best antiproliferative activity against the cell lines HeLa and 4T1. Only, the compound H16 decreased 32% cell proliferation against HepG2 cell line. The compounds H5, H16, E2, E16, and C1 did not affect the proliferation of the 3T3 cell line. The molecular docking analysis showed that phthalimide derivatives have a greater affinity for DNMT1 than S-adenosyl-l-homocysteine, a potent DNMT1 inhibitor. However, molecular docking results do not correlate with their antiproliferative effects, suggesting another potential mechanism of action for the active compounds. 2021 artículo científico 1405-888X https://www.redalyc.org/articulo.oa?id=43271644010 https://www.redalyc.org/journal/432/43271644010/ https://www.redalyc.org/journal/432/43271644010/html/ https://www.redalyc.org/journal/432/43271644010/43271644010.epub https://www.redalyc.org/journal/432/43271644010/movil 10.22201/fesz.23958723e.2021.314 en http://www.redalyc.org/revista.oa?id=432 Tip Revista Especializada en Ciencias Químico-Biológicas application/pdf Universidad Nacional Autónoma de México Tip Revista Especializada en Ciencias Químico-Biológicas (México) Vol.24
title In vitro and in silico biological evaluation of phthalimide derivatives as antiproliferative agents
topic Biología
phthalimide
Antiproliferative
molecular docking
DNA methyltransferase 1
url https://www.redalyc.org/articulo.oa?id=43271644010
https://www.redalyc.org/journal/432/43271644010/
https://www.redalyc.org/journal/432/43271644010/html/
https://www.redalyc.org/journal/432/43271644010/43271644010.epub
https://www.redalyc.org/journal/432/43271644010/movil